Neuroimaging Studies of Chronic Primary Headaches Using Positron Emission Tomography and Magnetic Resonance Imaging
1 other identifier
observational
78
1 country
1
Brief Summary
Investigators hypothesize that chronic primary headaches are accompanied by a discrete pattern of brain metabolism and activity involving brain structures related to the development of acute exacerbations as well as pain modulation. Such structures include the brainstem, hypothalamus, and orbitofrontal cortex and can be defined using functional brain imaging.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2011
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 26, 2012
CompletedFirst Posted
Study publicly available on registry
December 4, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedJune 30, 2015
June 1, 2015
3.8 years
November 26, 2012
June 26, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pattern of brain metabolism using positron emission tomography(PET).
Neuroimaging Studies of Chronic Primary Headaches Using Positron Emission Tomography and Magnetic Resonance Imaging to determine the pattern of brain metabolism.
Estimated to be approximately three years post baseline
Changes of resting state brain networks using magnetic resonance imaging (MRI)
Neuroimaging Studies of Chronic Primary Headaches Using Positron Emission Tomography and Magnetic Resonance Imaging (MRI) To determine any changes of resting state brain networks
Estimated to be approximately three years post baseline
Study Arms (3)
Control
Headache-free subjects.
Episodic migraine
Patients with less that 15 headache days per month that fulfill International Classification of Headache Disorders 2R (ICHD-2nd edition Revised)- criteria for Episodic Migraine.
Chronic migraine
Patients that fulfill International Classification of Headache Disorders (ICHD)-2R criteria for chronic migraine (more than 15 days per month).
Eligibility Criteria
Patients with episodic migraine, chronic migraine and control patients. Definitions are taken for the International Classification of Headache Disorders-2nd Edition (see references).
You may qualify if:
- Patients aged 18-65
- No medical contraindication.
- Chronic headache group:
- Patients with chronic primary headaches who are experiencing phases with background pain as well as habitual pain exacerbations.
- Able to provide informed consent.
- Not pregnant or planning to become so, with a pregnancy test prior to scanning.
- Control group and Episodic migraine group:
- Patients with episodic migraine
- Able to provide informed consent.
- Not pregnant or planning to become so, with a pregnancy test prior to scanning.
You may not qualify if:
- Taking a migraine preventive currently or in the last fifteen days.
- Known claustrophobia
- Patient is pregnant, planning to be pregnant, or becomes pregnant.
- Patients with metal implants.
- Patients who have had a study involving radiation within the one year prior to enrolling in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of California, San Franciscolead
- Allergancollaborator
Study Sites (1)
UCSF
San Francisco, California, 94115 & 94158, United States
Related Publications (26)
Welch KM, Goadsby PJ. Chronic daily headache: nosology and pathophysiology. Curr Opin Neurol. 2002 Jun;15(3):287-95. doi: 10.1097/00019052-200206000-00011.
PMID: 12045727BACKGROUNDScher AI, Stewart WF, Liberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998 Jul-Aug;38(7):497-506. doi: 10.1046/j.1526-4610.1998.3807497.x.
PMID: 15613165BACKGROUNDBigal ME, Serrano D, Reed M, Lipton RB. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology. 2008 Aug 19;71(8):559-66. doi: 10.1212/01.wnl.0000323925.29520.e7.
PMID: 18711108BACKGROUNDBergerot A, Holland PR, Akerman S, Bartsch T, Ahn AH, MaassenVanDenBrink A, Reuter U, Tassorelli C, Schoenen J, Mitsikostas DD, van den Maagdenberg AM, Goadsby PJ. Animal models of migraine: looking at the component parts of a complex disorder. Eur J Neurosci. 2006 Sep;24(6):1517-34. doi: 10.1111/j.1460-9568.2006.05036.x.
PMID: 17004916BACKGROUNDGoadsby PJ, Lipton RB, Ferrari MD. Migraine--current understanding and treatment. N Engl J Med. 2002 Jan 24;346(4):257-70. doi: 10.1056/NEJMra010917. No abstract available.
PMID: 11807151BACKGROUNDAfridi SK, Goadsby PJ. Neuroimaging of migraine. Curr Pain Headache Rep. 2006 Jun;10(3):221-4. doi: 10.1007/s11916-006-0049-4.
PMID: 18778577BACKGROUNDWeiller C, May A, Limmroth V, Juptner M, Kaube H, Schayck RV, Coenen HH, Diener HC. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995 Jul;1(7):658-60. doi: 10.1038/nm0795-658.
PMID: 7585147BACKGROUNDBahra A, Matharu MS, Buchel C, Frackowiak RS, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet. 2001 Mar 31;357(9261):1016-7. doi: 10.1016/s0140-6736(00)04250-1.
PMID: 11293599BACKGROUNDAfridi SK, Matharu MS, Lee L, Kaube H, Friston KJ, Frackowiak RS, Goadsby PJ. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain. 2005 Apr;128(Pt 4):932-9. doi: 10.1093/brain/awh416. Epub 2005 Feb 10.
PMID: 15705611BACKGROUNDAfridi SK, Giffin NJ, Kaube H, Friston KJ, Ward NS, Frackowiak RS, Goadsby PJ. A positron emission tomographic study in spontaneous migraine. Arch Neurol. 2005 Aug;62(8):1270-5. doi: 10.1001/archneur.62.8.1270.
PMID: 16087768BACKGROUNDDenuelle M, Fabre N, Payoux P, Chollet F, Geraud G. Hypothalamic activation in spontaneous migraine attacks. Headache. 2007 Nov-Dec;47(10):1418-26. doi: 10.1111/j.1526-4610.2007.00776.x.
PMID: 18052951BACKGROUNDGoadsby PJ, Hargreaves R. Refractory migraine and chronic migraine: pathophysiological mechanisms. Headache. 2008 Oct;48(9):1399-405. doi: 10.1111/j.1526-4610.2008.01274.x.
PMID: 19006557BACKGROUNDFumal A, Laureys S, Di Clemente L, Boly M, Bohotin V, Vandenheede M, Coppola G, Salmon E, Kupers R, Schoenen J. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain. 2006 Feb;129(Pt 2):543-50. doi: 10.1093/brain/awh691. Epub 2005 Dec 5.
PMID: 16330505BACKGROUNDValet M, Sprenger T, Boecker H, Willoch F, Rummeny E, Conrad B, Erhard P, Tolle TR. Distraction modulates connectivity of the cingulo-frontal cortex and the midbrain during pain--an fMRI analysis. Pain. 2004 Jun;109(3):399-408. doi: 10.1016/j.pain.2004.02.033.
PMID: 15157701BACKGROUNDRolke R, Baron R, Maier C, Tolle TR, Treede -DR, Beyer A, Binder A, Birbaumer N, Birklein F, Botefur IC, Braune S, Flor H, Huge V, Klug R, Landwehrmeyer GB, Magerl W, Maihofner C, Rolko C, Schaub C, Scherens A, Sprenger T, Valet M, Wasserka B. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain. 2006 Aug;123(3):231-243. doi: 10.1016/j.pain.2006.01.041. Epub 2006 May 11.
PMID: 16697110BACKGROUNDRaichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):676-82. doi: 10.1073/pnas.98.2.676.
PMID: 11209064BACKGROUNDGreicius MD, Krasnow B, Reiss AL, Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):253-8. doi: 10.1073/pnas.0135058100. Epub 2002 Dec 27.
PMID: 12506194BACKGROUNDCalhoun VD, Adali T, Stevens MC, Kiehl KA, Pekar JJ. Semi-blind ICA of fMRI: A method for utilizing hypothesis-derived time courses in a spatial ICA analysis. Neuroimage. 2005 Apr 1;25(2):527-38. doi: 10.1016/j.neuroimage.2004.12.012.
PMID: 15784432BACKGROUNDMatharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain. 2004 Jan;127(Pt 1):220-30. doi: 10.1093/brain/awh022. Epub 2003 Nov 7.
PMID: 14607792BACKGROUNDSprenger T, Ruether KV, Boecker H, Valet M, Berthele A, Pfaffenrath V, Woller A, Tolle TR. Altered metabolism in frontal brain circuits in cluster headache. Cephalalgia. 2007 Sep;27(9):1033-42. doi: 10.1111/j.1468-2982.2007.01386.x. Epub 2007 Jul 30.
PMID: 17666083BACKGROUNDHeadache Classification Committee of The International Headache Society. The International Classification of Headache Disorders (second edition). Cephalalgia 2004;24(Suppl 1):1-160.
BACKGROUNDFrackowiak RS, Friston KJ. Functional neuroanatomy of the human brain: positron emission tomography--a new neuroanatomical technique. J Anat. 1994 Apr;184 ( Pt 2)(Pt 2):211-25.
PMID: 8014115BACKGROUNDTalairach J, Tournoux P. Coplanar Stereotaxic Atlas of the Human Brain. New York: Thieme; 1988.
BACKGROUNDValk PE, Delbeke D, Bailey DL, D.W. T, Maisey MN. Positron Emission Tomography: Springer; 2006.
BACKGROUNDSprenger T, Seifert CL, Valet M, Staehle KS, Tölle TR, Foerschler A, Zimmer C, Goadsby PJ. Abnormal Interictal Resting State Activity in Episodic Migraine. Presented at the 62nd Annual Meeting of the American Academy of Neurology 2010, Toronto.
BACKGROUNDHeadache Classification Committee; Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Gobel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 Jun;26(6):742-6. doi: 10.1111/j.1468-2982.2006.01172.x.
PMID: 16686915BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amy Tso, MD
University of California, San Francisco
- PRINCIPAL INVESTIGATOR
Peter Goadsby, MD PhD
University of California, San Francisco
- PRINCIPAL INVESTIGATOR
Amy Gelfand, MD
University of California, San Francisco
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2012
First Posted
December 4, 2012
Study Start
September 1, 2011
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
June 30, 2015
Record last verified: 2015-06